MTOR and hepatocellular carcinoma: The MTOR signaling pathway played a crucial role in HCC metabolism and contributed to HCC therapy resistance40, while the NOTCH signaling pathway was related to inflammatory microenvironment41, and targeting to NOTCH signaling pathways showed therapeutic potential for HCC patients42.